Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Update on bTB vaccine

MPs warn vaccine is not a complete solution

In a report published on June 5, the Environment, Food and Rural Affairs Committee (EFRACom), warned that vaccination will not provide a complete solution to bovine TB (bTB).

Launching the report into the progress of a vaccine, EFRACom chair Anne McIntosh said vaccination is expensive, does not guarantee protection and will not on its own solve the problems caused by bTB.

"The Government is right to invest millions of pounds in developing vaccines against bovine TB. We should use every tool to combat this disease, but vaccination alone will not, at least in the short-term, provide a complete solution.

"Vaccines have no impact on already infected animals, offer a range of protection to those that aren’t infected, and will be expensive to deploy."

Small-scale studies in Ethiopia and Mexico have found the protective effect of a cattle vaccine to be 56-68 per cent. EFRACom warn that this is not a high enough level of protection to immediately solve the problem.

The injectable badger vaccine, which has been available since 2010, "could create a healthier badger population", according to Ms McIntosh. It is, however, expensive, she added, meaning it should be used in areas where it will have the most impact.

An oral baited badger vaccine is felt to be "the most likely way to create a healthy badger population," offering a cheaper and more practical alternative to vaccination.

Concluding, Ms McIntosh called on the government to investigate whether the gamma interferon test - a blood test that is more sensitive than the skin test currently relied upon - could be used more widely to test for bTB, despite the cost.

She added that ongoing research projects could make a real difference in eradicating the disease in the UK, and the government's continuing investment in this research is crucial.

 

Related News
Reseach offers hope for bTB vaccine
Cattle bTB vaccine unlikely until 2023

 

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.